Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transurethral Resection of the Bladder”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Not applicableUnknownNCT05063292
What this trial is testing

Effect of Prewarming On Skin Temperature Changes

Who this might be right for
Spinal AnesthesiaHypothermia Following AnesthesiaPrewarming+2 more
Bozyaka Training and Research Hospital 60
Large-scale testing (Phase 3)Study completedNCT07279792
What this trial is testing

Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNonmuscle Invasive Bladder CancerIrrigation+3 more
Ain Shams University 150
Not applicableStudy completedNCT07481123
What this trial is testing

COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT

Who this might be right for
Bladder Cancer
Yavuz Saygılı 60
Testing effectiveness (Phase 2)Ended earlyNCT02010203
What this trial is testing

HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT

Who this might be right for
Bladder Cancer
Heat Biologics 104
Not applicableStudy completedNCT02012036
What this trial is testing

Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice

Who this might be right for
Photodynamic Transurethral Resection of the Bladder (TUR-B)
Ipsen 400
Post-approval studies (Phase 4)UnknownNCT03029676
What this trial is testing

The Assessment of POCD After TURBT Under Spinal Anesthesia

Who this might be right for
Bladder TumorPostoperative Cognitive Dysfunction
Medical University of Warsaw 200
Not applicableNot Yet RecruitingNCT07463963
What this trial is testing

Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial

Who this might be right for
Bladder CancerTransurethral Resection of the BladderUrinary Tract Infection Bacterial
Poitiers University Hospital 2,600
Not applicableStudy completedNCT03463499
What this trial is testing

The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients

Who this might be right for
Interstitial Cystitis
Samsung Medical Center 62
Not applicableStudy completedNCT04900259
What this trial is testing

The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations

Who this might be right for
Bladder CancerCovid19
Ankara Training and Research Hospital 183
Not applicableStudy completedNCT05376631
What this trial is testing

Effect of Fresh Gas Flow on Emergence Time

Who this might be right for
Bladder Cancer
Asan Medical Center 54
Not applicableUnknownNCT04664816
What this trial is testing

Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Mansoura University 110
Large-scale testing (Phase 3)UnknownNCT00003725
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
Anthra Pharmaceuticals 300
Large-scale testing (Phase 3)Ended earlyNCT02563561
What this trial is testing

Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT)

Who this might be right for
Bladder Cancer
Spectrum Pharmaceuticals, Inc 62
Not applicableStudy completedNCT07642102
What this trial is testing

Evaluation of the Role of Early Second Look TURBT in Management of High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Transurethral Resection of Bladder Tumor
Ain Shams University 70
Not applicableStudy completedNCT07445451
What this trial is testing

Magnesium vs. Dexmedetomidine in TURBT Under Spinal Anesthesia

Who this might be right for
Bladder TumorsSpinal AnesthesiaPostoperative Pain+3 more
Dr. Lutfi Kirdar Kartal Training and Research Hospital 93
Not applicableStudy completedNCT05872451
What this trial is testing

Current Intensity for the Obturator Nerve Block

Who this might be right for
Bladder Tumor
Chosun University Hospital 30
Not applicableStudy completedNCT01166230
What this trial is testing

Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB

Who this might be right for
Bladder Cancer
Photocure 551
Not applicableStudy completedNCT01963988
What this trial is testing

Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Ulcer in Bladder Pain Syndrome Patients

Who this might be right for
Bladder Pain Syndrome
Samsung Medical Center 126
Not applicableLooking for participantsNCT07130578
What this trial is testing

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerLiquid Biopsy
Tianjin Medical University Second Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00191711
What this trial is testing

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 43
Load More Results